APA
Pyzer A. R., Stroopinsky D., Rosenblatt J., Anastasiadou E., Rajabi H., Washington A., Tagde A., Chu J., Coll M., Jiao A. L., Tsai L. T., Tenen D. E., Cole L., Palmer K., Ephraim A., Leaf R. K., Nahas M., Apel A., Bar-Natan M., Jain S., McMasters M., Mendez L., Arnason J., Raby B. A., Slack F., Kufe D. & Avigan D. (20171215). MUC1 inhibition leads to decrease in PD-L1 levels via upregulation of miRNAs. : Leukemia.
Chicago
Pyzer A R, Stroopinsky D, Rosenblatt J, Anastasiadou E, Rajabi H, Washington A, Tagde A, Chu J-H, Coll M, Jiao A L, Tsai L T, Tenen D E, Cole L, Palmer K, Ephraim A, Leaf R K, Nahas M, Apel A, Bar-Natan M, Jain S, McMasters M, Mendez L, Arnason J, Raby B A, Slack F, Kufe D and Avigan D. 20171215. MUC1 inhibition leads to decrease in PD-L1 levels via upregulation of miRNAs. : Leukemia.
Harvard
Pyzer A. R., Stroopinsky D., Rosenblatt J., Anastasiadou E., Rajabi H., Washington A., Tagde A., Chu J., Coll M., Jiao A. L., Tsai L. T., Tenen D. E., Cole L., Palmer K., Ephraim A., Leaf R. K., Nahas M., Apel A., Bar-Natan M., Jain S., McMasters M., Mendez L., Arnason J., Raby B. A., Slack F., Kufe D. and Avigan D. (20171215). MUC1 inhibition leads to decrease in PD-L1 levels via upregulation of miRNAs. : Leukemia.
MLA
Pyzer A R, Stroopinsky D, Rosenblatt J, Anastasiadou E, Rajabi H, Washington A, Tagde A, Chu J-H, Coll M, Jiao A L, Tsai L T, Tenen D E, Cole L, Palmer K, Ephraim A, Leaf R K, Nahas M, Apel A, Bar-Natan M, Jain S, McMasters M, Mendez L, Arnason J, Raby B A, Slack F, Kufe D and Avigan D. MUC1 inhibition leads to decrease in PD-L1 levels via upregulation of miRNAs. : Leukemia. 20171215.